{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T20:50:14Z","timestamp":1783457414554,"version":"3.55.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005205","name":"Janssen Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005205","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1111\/jth.15673","type":"journal-article","created":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T04:01:04Z","timestamp":1644984064000},"page":"1193-1205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant\/antiplatelet regimen vs antiplatelet therapy alone"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9428-4408","authenticated-orcid":false,"given":"Scott D.","family":"Berkowitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6192-1741","authenticated-orcid":false,"given":"Rupert M.","family":"Bauersachs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0046-0264","authenticated-orcid":false,"given":"Michael","family":"Szarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1012-7307","authenticated-orcid":false,"given":"Mark\u00a0R.","family":"Nehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5664-6439","authenticated-orcid":false,"given":"E. Sebastian","family":"Debus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2393-0855","authenticated-orcid":false,"given":"Manesh R.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3692-7441","authenticated-orcid":false,"given":"Sonia\u00a0S.","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1073-3721","authenticated-orcid":false,"given":"Warren H.","family":"Capell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5830-0511","authenticated-orcid":false,"given":"Connie N.","family":"Hess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3413-7836","authenticated-orcid":false,"given":"Judy","family":"Hsia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0905-2806","authenticated-orcid":false,"given":"Nicholas J.","family":"Leeper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3524-4043","authenticated-orcid":false,"given":"David","family":"Brasil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2725-8776","authenticated-orcid":false,"given":"Lajos","family":"M\u00e1ty\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6493-3799","authenticated-orcid":false,"given":"Marianne","family":"Brodmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8213-232X","authenticated-orcid":false,"given":"Eva","family":"Muehlhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2468-2523","authenticated-orcid":false,"given":"Lloyd P.","family":"Haskell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9860-3584","authenticated-orcid":false,"given":"Marc P.","family":"Bonaca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.15673_bb0010","doi-asserted-by":"crossref","first-page":"8295054","DOI":"10.1155\/2019\/8295054","article-title":"Burden of coronary artery disease and peripheral artery disease: a literature review","volume":"2019","author":"Bauersachs","year":"2019","journal-title":"Cardiovasc Ther"},{"key":"10.1111\/jth.15673_bb0015","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1161\/CIRCULATIONAHA.112.000679","article-title":"Vorapaxar in patients with peripheral artery disease: results from TRA2{degrees}P\u2010TIMI 50","volume":"127","author":"Bonaca","year":"2013","journal-title":"Circulation"},{"key":"10.1111\/jth.15673_bb0020","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1056\/NEJMcp1006054","article-title":"Acute limb ischemia","volume":"366","author":"Creager","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.15673_bb0025","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1161\/ATVBAHA.119.312864","article-title":"Pathologic disparities between peripheral artery disease and coronary artery disease","volume":"40","author":"Narula","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.15673_bb0030","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.jacc.2018.08.002","article-title":"Pathology of peripheral artery disease in patients with critical limb ischemia","volume":"72","author":"Narula","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/jth.15673_bb0035","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","article-title":"Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis","volume":"382","author":"Fowkes","year":"2013","journal-title":"Lancet"},{"key":"10.1111\/jth.15673_bb0040","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1016\/j.jvs.2014.12.009","article-title":"Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: Management of asymptomatic disease and claudication","volume":"61","author":"Conte","year":"2015","journal-title":"J Vasc Surg"},{"key":"10.1111\/jth.15673_bb0045","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/1358863X10373299","article-title":"Influence of polyvascular disease on cardiovascular event rates. Insights from the REACH Registry","volume":"15","author":"Suarez","year":"2010","journal-title":"Vasc Med"},{"key":"10.1111\/jth.15673_bb0050","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1016\/j.jacc.2018.09.078","article-title":"Cardiovascular and limb outcomes in patients with diabetes and peripheral artery disease: The EUCLID Trial","volume":"72","author":"Low Wang","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/jth.15673_bb0055","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1056\/NEJMoa1200933","article-title":"Vorapaxar in the secondary prevention of atherothrombotic events","volume":"366","author":"Morrow","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.15673_bb0060","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.jacc.2017.07.768","article-title":"Efficacy and safety of ticagrelor over time in patients with prior MI in PEGASUS\u2010TIMI 54","volume":"70","author":"Bonaca","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/jth.15673_bb0065","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N Engl J Med"},{"issue":"1009\u201317","key":"10.1111\/jth.15673_bb0070","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.jvs.2016.03.429","article-title":"Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization","volume":"64","author":"Sigvant","year":"2016","journal-title":"J Vasc Surg"},{"key":"10.1111\/jth.15673_bb0075","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1161\/CIRCULATIONAHA.116.025880","article-title":"Ticagrelor compared with clopidogrel in patients with prior lower extremity revascularization for peripheral artery disease","volume":"135","author":"Jones","year":"2017","journal-title":"Circulation"},{"key":"10.1111\/jth.15673_bb0080","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jacc.2019.11.050","article-title":"Long\u2010term outcomes and associations with major adverse limb events after peripheral artery revascularization","volume":"75","author":"Hess","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/jth.15673_bb0085","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","article-title":"Rivaroxaban in peripheral artery disease after revascularization","volume":"382","author":"Bonaca","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.15673_bb0090","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jacc.2021.05.003","article-title":"Total Ischemic event reduction with rivaroxaban after peripheral arterial revascularization in the VOYAGER PAD trial","volume":"78","author":"Bauersachs","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/jth.15673_bb0095","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ahj.2018.01.011","article-title":"Rationale and design for the Vascular Outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral artery disease (VOYAGER PAD)","volume":"199","author":"Capell","year":"2018","journal-title":"Am Heart J"},{"key":"10.1111\/jth.15673_bb0100","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10985-019-09462-4","article-title":"Modeling marginal features in studies of recurrent events in the presence of a terminal event","volume":"25","author":"Andersen","year":"2019","journal-title":"Lifetime Data Anal"},{"key":"10.1111\/jth.15673_bb0105","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1080\/01621459.1989.10478874","article-title":"The robust inference for the Cox proportional hazards model","volume":"84","author":"Lin","year":"1989","journal-title":"J Am Statis Assoc"},{"key":"10.1111\/jth.15673_bb0110","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1001\/jama.289.19.2554","article-title":"Composite outcomes in randomized trials: greater precision but with greater uncertainty?","volume":"289","author":"Freemantle","year":"2003","journal-title":"JAMA"},{"key":"10.1111\/jth.15673_bb0115","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1161\/CIRCULATIONAHA.117.033065","article-title":"Comparison of time\u2010to\u2010first event and recurrent\u2010event methods in randomized clinical trials","volume":"138","author":"Claggett","year":"2018","journal-title":"Circulation"},{"key":"10.1111\/jth.15673_bb0120","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/ejhf.29","article-title":"Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM\u2010Preserved","volume":"16","author":"Rogers","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"10.1111\/jth.15673_bb0125","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jacc.2015.10.077","article-title":"Reduction in total cardiovascular events with ezetimibe\/simvastatin post\u2010acute coronary syndrome: The IMPROVE\u2010IT trial","volume":"67","author":"Murphy","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/jth.15673_bb0130","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1001\/jama.297.11.1197","article-title":"One\u2010year cardiovascular event rates in outpatients with atherothrombosis","volume":"297","author":"Steg","year":"2007","journal-title":"JAMA"},{"key":"10.1111\/jth.15673_bb0135","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1001\/jama.2010.1322","article-title":"Comparative determinants of 4\u2010year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis","volume":"304","author":"Bhatt","year":"2010","journal-title":"JAMA"},{"key":"10.1111\/jth.15673_bb0140","first-page":"e726","article-title":"2016 AHA\/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"135","author":"Gerhard\u2010Herman","year":"2017","journal-title":"Circulation"},{"issue":"23","key":"10.1111\/jth.15673_bb0145","doi-asserted-by":"crossref","first-page":"1831\u20101841","DOI":"10.1161\/CIRCULATIONAHA.121.055146","article-title":"Reduction in acute limb ischemia with rivaroxaban versus placebo in peripheral artery disease after lower extremity revascularization: insights from VOYAGER PAD","volume":"144","author":"Hess","year":"2021","journal-title":"Circulation"},{"key":"10.1111\/jth.15673_bb0150","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1161\/CIRCULATIONAHA.117.024469","article-title":"A Structured review of antithrombotic therapy in peripheral artery disease with a focus on revascularization: A TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) Initiative","volume":"135","author":"Hess","year":"2017","journal-title":"Circulation"},{"key":"10.1111\/jth.15673_bb0155","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1161\/CIRCULATIONAHA.120.050465","article-title":"Rivaroxaban and aspirin in peripheral artery disease lower extremity revascularization: impact of concomitant clopidogrel on efficacy and safety","volume":"142","author":"Hiatt","year":"2020","journal-title":"Circulation"},{"key":"10.1111\/jth.15673_bb0160","unstructured":"Hess CN, et al. Risk of venous thromboembolism and effect of rivaroxaban in patients with symptomatic peripheral artery disease after lower extremity revascularization, submitted for publication."},{"key":"10.1111\/jth.15673_bb0165","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1161\/CIRCULATIONAHA.118.033580","article-title":"Combination antiplatelet and oral anticoagulant therapy in patients with coronary and peripheral artery disease","volume":"139","author":"Gurbel","year":"2019","journal-title":"Circulation"},{"key":"10.1111\/jth.15673_bb0170","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa060989","article-title":"Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events","volume":"354","author":"Bhatt","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.15673_bb0175","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/eurheartj\/ehn534","article-title":"Patients with peripheral arterial disease in the CHARISMA trial","volume":"30","author":"Cacoub","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1111\/jth.15673_bb0180","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jvs.2010.04.027","article-title":"Results of the randomized, placebo\u2010controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial","volume":"52","author":"Belch","year":"2010","journal-title":"J Vasc Surg"},{"key":"10.1111\/jth.15673_bb0185","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1161\/CIRCULATIONAHA.109.853085","article-title":"Combination antithrombotic therapies","volume":"121","author":"Gurbel","year":"2010","journal-title":"Circulation"},{"key":"10.1111\/jth.15673_bb0190","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1161\/CIRCRESAHA.118.313155","article-title":"Antithrombotic agents","volume":"124","author":"Chan","year":"2019","journal-title":"Circ Res"},{"key":"10.1111\/jth.15673_bb0195","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1182\/bloodadvances.2017013573","article-title":"Inhibitory mechanisms of very low\u2010dose rivaroxaban in non\u2010ST\u2010elevation myocardial infarction","volume":"2","author":"Borst","year":"2018","journal-title":"Blood Adv"},{"key":"10.1111\/jth.15673_bb0200","article-title":"Low\u2010dose rivaroxaban and aspirin among patients with peripheral artery disease: a meta\u2010analysis of the COMPASS and VOYAGER trials","author":"Anand","year":"2021","journal-title":"Eur J Prev Cardiol"},{"key":"10.1111\/jth.15673_bb0205","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","article-title":"Atherosclerosis","volume":"5","author":"Libby","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"10.1111\/jth.15673_bb0210","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1056\/NEJMoa022157","article-title":"An association between atherosclerosis and venous thrombosis","volume":"348","author":"Prandoni","year":"2003","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"10.1111\/jth.15673_bb0215","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1538-7836.2007.02467.x","article-title":"Venous thromboembolism and atherosclerosis: is there a link?","volume":"5","author":"Prandoni","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15673_bb0220","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1161\/CIRCULATIONAHA.116.025024","article-title":"Smoking","volume":"135","author":"Anand","year":"2017","journal-title":"Circulation"},{"key":"10.1111\/jth.15673_bb0225","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1161\/CIRCULATIONAHA.107.709204","article-title":"Cardiovascular risk factors and venous thromboembolism","volume":"117","author":"Ageno","year":"2008","journal-title":"Circulation"},{"key":"10.1111\/jth.15673_bb0230","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1016\/j.jacc.2020.04.071","article-title":"Post\u2010Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill Patients","volume":"75","author":"Spyropoulos","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/jth.15673_bb0235","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.thromres.2021.05.009","article-title":"Frequency and incidence of arterial events in patients with venous thromboembolism compared to the general population: A systematic review and meta\u2010analysis of cohort studies","volume":"203","author":"Noumegni","year":"2021","journal-title":"Thromb Res"},{"key":"10.1111\/jth.15673_bb0240","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/01.sla.0000103067.10695.74","article-title":"Venous claudication in iliofemoral thrombosis: long\u2010term effects on venous hemodynamics, clinical status, and quality of life","volume":"239","author":"Delis","year":"2004","journal-title":"Ann Surg"},{"key":"10.1111\/jth.15673_bb0245","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11739-019-02238-6","article-title":"Is there a link between venous and arterial thrombosis? A Reappraisal","volume":"15","author":"Prandoni","year":"2020","journal-title":"Intern Emerg Med"},{"key":"10.1111\/jth.15673_bb0250","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1056\/NEJMra1011670","article-title":"The hemostatic system as a modulator of atherosclerosis","volume":"364","author":"Borissoff","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.15673_bb0255","first-page":"21","article-title":"Rivaroxaban and aspirin in patients with symptomatic lower extremity peripheral artery disease a subanalysis of the COMPASS randomized clinical trial","volume":"6","author":"Kaplovitch","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1111\/jth.15673_bb0260","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1016\/j.jacc.2018.03.008","article-title":"Major adverse limb events and mortality in patients with peripheral artery disease: the COMPASS trial","volume":"71","author":"Anand","year":"2018","journal-title":"J Am Coll Cardiol"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.15673","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jth.15673","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622001659?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622001659?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.15673","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:34:56Z","timestamp":1761536096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622001659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S1538783622001659"],"URL":"https:\/\/doi.org\/10.1111\/jth.15673","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant\/antiplatelet regimen vs antiplatelet therapy alone","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.15673","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 The Authors. Journal of Thrombosis and Haemostasis published by ELSEVIER INC. on behalf of International Society on Thrombosis and Haemostasis","name":"copyright","label":"Copyright"}]}}